Hepatitis E virus (HEV) is a human pathogen that causes acute hepatitis. When an HEV capsid protein containing a 52 amino acid deletion at the C-terminus and a 111 amino acid deletion at the N-terminus is expressed in insect cells, the recombinant HEV capsid protein can self-assemble into a T=1 virus-like particle (VLP) that retains the antigenicity of the native HEV virion. In this study, we used cryo-electron microscopy and image reconstruction to show that anti-HEV monoclonal antibodies bind to the protruding domain of the capsid protein at the lateral side of the spikes. Molecular docking of the HEV VLP crystal structure revealed that the Fab224 covered three PORF2 surface loops at the top part of the spike. We also determined the structure of a chimeric HEV VLP and located the inserted B-cell tag, an epitope of 11 amino acids coupled to the C-terminal end of the recombinant ORF2 protein. The binding site of Fab224 appeared distinct from the location of the inserted B-cell tag, suggesting that the chimeric VLP could elicit immunity against both HEV and an inserted foreign epitope. Therefore, the T=1 HEV VLP is a novel delivery system for displaying foreign epitopes at the VLP surface in order to induce antibodies against both HEV and the inserted epitope.
INTRODUCTION
Hepatitis E virus (HEV) is a causative agent of acute hepatitis in humans and is primarily transmitted via the fecal-oral route. HEV is thus resistant to the low pH and digestive enzymes associated with the stomach and gastrointestinal tract. HEV regularly causes epidemics in many tropical and subtropical countries. In India, 101 outbreaks were confirmed by serological analysis in the state of Maharashtra in the last 5 years (6) , and in India, the lifetime risk of HEV infection exceeds 60% (27) . Sporadic cases have also been reported in HEV-endemic regions, as well as in non-endemic areas. Although some of these cases were associated with travel, many cases involved patients without history of travel to HEV endemic regions. Accumulating evidence suggests that sporadic infection occurs through a zoonotic route and is not limited to developing countries. Seroprevalence suggests hepatitis E infection may also be prevalent in the United States (17) , France (3), and Japan (18) . The overall mortality rate of HEV infection during an outbreak generally ranges from 1 to 15% and the highest mortality occurs in pregnant women, with fatality rates of up to 30% (19).
The HEV virion is composed of a 7.2kB single-stranded RNA molecule and a 32-34 nm icosahedral capsid. The HEV genome contains three open reading frames (ORFs). The capsid protein, encoded by the second open reading frame (ORF2) located at the 3' terminus of the genome, comprises 660 amino acids and is responsible for most capsid-related functions, such as assembly, host interaction, and immunogenicity. Recombinant ORF2 proteins can induce antibodies that block HEV infection in non-human primates (12, 26). Four major antigenic domains were predicted to be located within the C-terminal 268 amino acids of ORF2 protein, one domain was experimentally identified as a neutralization epitope in the Sar-55 ORF2 capsid protein (24, 25) . However, the minimal peptide needed to induce anti-HEV neutralizing on October 20, 2017 by guest http://jvi.asm.org/ Downloaded from 4 antibodies contains residues 459-607 of the ORF2 protein (32) , which is much longer than a linear antigenic epitope, suggesting that the neutralization epitope is conformational.. Therefore, the detailed structure of HEV capsid protein is required in order to understand the organization of HEV epitopes.
Currently, there are 1,600 HEV genomic sequences available through the International Nucleotide Sequence Database Collaboration. They are classified into four genotypes which vary by geographic distribution and host range (10) . In contrast, only a single serotype has been identified, suggesting that the immuno-dominant domain of HEV is highly conserved among genotypes. Antibodies from any one of the four genotypes cross-react with the capsid protein of genotype-1 (7).
Like other hepatitis viruses, HEV does not propagate well in currently available cell culture systems. Hepatitis E preventive strategies so far rely on the use of ORF2-derived recombinant protein (16) . When expressed in insect cells, truncated recombinant ORF2 protein (PORF2) with 52 residues deleted from the C-terminus and 111 residues deleted from the Nterminus, self-assembles into virus-like particles (VLPs) (15) . Our previous structural analysis of recombinant HEV VLP by cryo-electron microscopy (cryo-EM) provided the first understanding of the quaternary arrangement of PORF2.
??? The essential assembly element of PORF2 protein contained amino acids 125-600 (13) and the reconstructed VLP displayed a T=1 icosahedral particle composed of 60 copies of truncated PORF2 (29) . Recently, crystal structures were reported for genotype-1 T=1 VLP (30), genotype-3 T=1 VLP (31), and genotype-4 T=1 VLP (8) , revealing that PORF2 is composed of three domains: S-domain, M-domain and P domain. The T=1 icosahedral shell is composed of 60 copies of S-domains, while the M-domain binds tightly to the S-domain and interacts with on October 20, 2017 by guest http://jvi.asm.org/ Downloaded from 5 two threefold-related M-domains to form a surface plateau at each of the three-fold axes. Two P domains are tightly associated as a dimeric-spike that protrudes from each of the icosahedral twofold axes. As a result, on a low resolution cryo-EM density map, the HEV T=1 VLP appears as an icosahedral particle with 30 spikes (29) .
Although these VLPs are smaller (270Å in diameter) than the native HEV virion (320-340Å), oral administration of HEV VLPs to experimental animals can induce anti-HEV antibodies that bind to native HEV (14) . When a B-cell tag of 11 amino acids on glycoprotein D of herpes simplex virus was covalently coupled to the C-terminal end of PORF2 (after residue 608), the fusion protein retained the ability of PORF2 to assembly and form chimeric T=1 icosahedral VLP that were capable of eliciting systemic and mucosal antibodies against both HEV capsid protein and the attached B-cell tag (20) . Therefore, the HEV T=1 VLP is a potential carrier for delivering not only HEV antigen but also foreign antigens or anti-viral drugs to the host immune system. However, rational design of HEV-based delivery vectors requires detailed information on HEV VLP structure as well as HEV immunodominant domains.
Here, we identified antigenic structures using cryo-EM and three-dimensional reconstruction. Our results indicate that the binding footprint of a neutralizing antibody covers the lateral side of the P domain, while a B-cell tag at the C-terminus does not alter the assembly of T=1 HEV VLP.
MATERIALS AND METHODS

Production and purification of anti-HEV monoclonal antibody Mab224
Eight-week-old female BALB/c mice were immunized at 0 and 4 weeks by intraperitoneal inoculation with HEV VLPs (100 ug/ml). Supernatants from microplate wells positive for hybridoma growth were screened by ELISA using recombinant HEV VLPs as the antigen. Hybridomas that secrete antibodies specific for HEV were subcloned three times by limiting dilution, after which they were considered to be monoclonal. Antibodies in the supernatants were isotyped using the Mouse Monoclonal Antibody Isotyping kit (Amersham, Little Chalfont, Buckinghamshire, U.K.) in accordance with the manufacturer's protocol. Hybridomas were grown in bulk in stationary flasks (Nunc, Roskilde, Denmark) using RPMI-1640 with 15% FCS. Antibodies were purified from cell supernatants using HiTrap protein G affinity columns (Pharmacia Biotech AB, Uppsala, Sweden) and stored at -80 ºC. Among all of the antibodies that were generated, Mab224, an immunoglobulin G1 (IgG1) isotype was chosen for structural analysis.
Preparation of Fab224 fragments
Isolated Fab224 fragments were prepared from purified mouse monoclonal antibodies by papain cleavage. A reducing L-cysteine buffer was used to activate the papain, and MAb224 was mixed with papain at a molar ratio of 100:1. The mixture was incubated overnight at 30 ºC.
The reaction was stopped by the addition of iodocetamide, and the product was analyzed by SDS-PAGE. The Fab224 fragments were purified using a 5-ml pre-packed Protein-A chromatography column (Pierce Protein Research) according to the manufacturer's instructions.
The Fc fragments and un-cleaved MAbs224 were trapped in the column due to their affinity for protein-A, while the Fab224 fragments were collected in the flow-through fraction. The Fab4 was prepared by phage display and purified according to the protocol described previously (24) . Briefly, chimpanzee 1441 was infected with HEV strain SAR-55. Bone marrow was aspirated from the iliac crest of this animal and antibody κ-chain gene and γ1-chain gene were amplified and cloned into pComb3H phage display vector and pGEM-T cloning vector (Promega) respectively, and transformed into E coli XL-1 Blue. The bacteria were then amplified and infected with helper phage VCS M13 at multiplicity of infection of 50 to produce a library displayed on surfaces of phage particles. Phage was panned on SAR-55 ORF2-coated ELISA wells; four rounds of panning were performed. After amplification of the selected library, the phagemid DNA was extracted and the vector was modified to remove the bacteriophage coat protein III-encoding region of the phage. The phagemid DNAs were religated and transformed into E coli XL-1 Blue to produce soluble Fabs. The vector pComb3H was constructed to encode a six-histidine tail at the end of the Fab fragment, thus facilitating Fab purification. Fab4 purity was determined by SDS-PAGE, followed by colloidal Coomassie brilliant blue staining.
Production and purification of HEV VLPs
The production and purification of HEV VLPs were conducted as described (13, 15, 20, 29) . Briefly, DNA fragments encoding the N-truncated ORF2 protein (for wild type VLPs) and the chimeric ORF2 protein (for VLPs/C-tag) were cloned using the baculovirus transfer vector by performing SDS-PAGE (gradient 8-25%) on the purified VLP/Fab complexes at a constant voltage using the Phast™ system (Pharmacia). The particle morphology of VLP/Fab complexes was examined by negative stain electron microscopy (EM) using 2% uranyl acetate.
Cryo-electron microscopy Sample preparation and cryo-EM were performed following previously described, wellestablished procedures (13, 29) . Briefly, a drop containing 3.5 µl of the sample was applied to a glow-discharged holey-carbon coated copper grid, blotted with a piece of filter paper for 3s to remove the extra liquid and quickly plunged into liquid ethane cooled by liquid nitrogen.
Samples were frozen in a thin layer of vitrified ice. The grid was then transferred into a Gatan 626DH cryo-holder and kept at a low temperature (-178 ºC) during the subsequent data collection. Micrographs were collected under a low-dose condition (< 10 e-/Å2) using Kodak SO163 film at a magnification of 45,000 X on a FEI CM-120 electron microscope operated at on October 20, 2017 by guest http://jvi.asm.org/ Downloaded from 10 120 kV, and particles were photographed at a defocus range from 1000 to 3000 nm. Micrographs were visually inspected and selected based on a suitable particle concentration, optimal ice thickness, and minimal specimen drift. Only micrographs fulfilling these criteria were analyzed.
Image processing
Selected micrographs were digitized using a Heidelberg Prime scanner D8200 (Heidelberg, Germany) at a 14 µm scanning step size, corresponding to 3.11 Å per pixel of specimen space. Particles were manually picked and centered by cross-correlating each one against the circular average image. The astigmatism and defocus value were evaluated by the superimposed power spectra from all particles within a single micrograph. The CTF first zero was approximately within the range of 17-20 Å -1 for the data used for the structural determination. The self-common-lines algorithm (4) was used to yield the initial models for VLP/C-tag, VLP/Fab4, and VLP/Fab224. The origins and orientations search for each particle was carried out iteratively using the polar Fourier transformation (PFT) algorithm running on an AMD MP1800 MHz dual-processor Linux workstation (2). Three-dimensional reconstructions were computed by combining a set of particles with orientations that spread evenly in an icosahedral asymmetric unit using the Fourier-Bessel algorithm and by superimposing 5-3-2 icosahedral symmetry. To examine the reliability of the three-dimensional reconstruction, the dataset was evenly divided into two parts at the final refinement step and two three-dimensional reconstructions were computed. The resolution was estimated using Fourier shell correlation proteins were recovered from cell cytoplasm where multiple forms of PORF2 were reported (15), the positive bands observed at low molecular weight may be the proteolytic products or degraded forms of ORF2 that contain the Fab224 binding sequence.
Two-dimensional electron cryo-micrographs
The chimeric VLPs (Fig 1C) and the Fab224-conjugated VLP complex (Fig 1D) showed circular profiles with spike-like densities that extended from the surface. As we observed previously (15, 29) , they appeared to have a white contrast center, indicating that they are empty particles lacking RNA (data not shown). The sizes of both VLPs were approximately 27 nm without taking into account the extra densities that extended from the VLP/Fab224 surface (Fig.   1D ).
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The cryo-EM structure of HEV/Fab224 was reconstructed from 615 images of individual particles and displayed T=1 icosahedral symmetry with 60 protein subunits that were arranged into 30 dimeric protruding spikes located at each icosahedral two-fold axis (Fig 2A) . Sixty Fab molecules were observed around each VLP particle, bound to the shoulder of the P domain. The
Fab density extended ~57 Å radially away from the spike surface. The density corresponding to the Fab was approximately equal in magnitude to that of the HEV VLP, indicating that most or all of the 60 binding sites were occupied by a Fab molecule. The density corresponding to the VLP capsid was removed from the cryo-EM map, producing a Fab differential density map that was used to pinpoint the binding site of the Fab224 antibody (Fig 3A and 3B ).
In addition, the structure of HEV VLP in complex with the neutralizing antibody Fab4 was determined by combining 264 individual images. Fab4 precipitates both the native HEV virion and recombinant PORF2 peptides but the reaction depends on the presence of amino acids 597-607 (25) . Three-dimensional reconstruction of the VLP/Fab4 complex showed 60 Fab molecules bound to each HEV VLP. Unlike the Fab224 VLP complex, the density corresponding to Fab4 was about one third of that of the capsid (Fig 2A) , suggesting that only 30-40% of the binding sites were occupied by the Fab. Moreover, the binding of Fab4 appeared deeper on the side-wall of the protruding domain towards the capsid shell, leaving its Fc domain exposed above the surface of the plateau (Fig 2A) . In contrast, the entire Fab224 stood mainly on the top of the P domain surface. The Fab224 and the Fab4 extend along the long axis of the P domain.
In both cases, no steric hindrance of the Fab on the P domain with the neighboring Fab (Fig 2A) .
To further analyze the Fab and HEV VLP binding interface, the crystal structure of genotype-1 PORF2 was docked onto the VLP/Fab224 cryo-EM density map. The genotype-1 PORF2 crystal structure (2ZZQ) is composed of three domains (30) , and these domains are in good agreement with those of genotype-3 and genotype-4 PORF2 (PDB accession number 2ZTN
and 3HAG, respectively) (8, 31) . The coordinates fitted very well with the cryo-EM density map without any adjustment (CC value = 80%). The atoms on the surface of the HEV VLP capsid were plotted and colored according to their radial distance, and overlapped with the density of the Fab at the surface plateau of the protruding spike (Fig 2B) .
The Fab224 interacted with the residues at the side of the ORF2 spike rather than with those residues on the spike plateau surface (Fig 3C) . The contact footprint did not overlap with the dimeric interface of the PORF2 spike. As expected, Fab224 recognizes a conformational epitopes and its binding site covers a surface composed of three loops including amino acids 470-493 in loop 1, amino acids 539-569 in loop 2, and amino acids 581-595 in loop 3 ( Fig 3D) .
Residues E479, D481, T484, Y485, and S487 from the AB loop and residues Y532, S533, and K534 from the CD loop were in close contact with the Fab molecule.
Structure of HEV chimeric VLP
Chimeric HEV VLP/C-tag was constructed using a PORF2 fusion protein in which a Bcell tag of 11 amino acids was incorporated into the C-terminus of PORF2 (Fig 1B) . VLP/C-tag can also be divided into two distinct layers, an icosahedral shell and a protruding spike (Fig 4A) . The spike projects outward from the icosahedral shell and is composed of a PORF2 dimer. The distance between two adjacent spikes was ~ 76 Å as measured between the centers of surface plateau. These results are consistent with the measurements of VLPs obtained either from Tn5 insect cells (29) or from Sf9 insect cells (13) and no detectable density was added onto the outer surface of the spike. No RNA density was detected within the chimeric VLP/C-tag.
The crystal structure fit very well within the VLP/C-tag density map (Fig 4B) , indicating that the C-terminal 11 amino acids insertion inhibits neither the dimer-dimer interactions nor the formation of T=1 VLP. When the density maps were contoured to cover 100%, the radii of the S domains were roughly the same for both the VLP/C-tag and the VLP/Fab224 maps, and the height of the protruding spikes appeared similar. Density difference was not observed from the docking (Fig 5) , suggesting that the inserted B-cell tag is flexible and less ordered. However, model fitting revealed that coordinates-unoccupied density appeared at the lateral side of the spike and underneath the Fab224 binding site (Fig 5A and 5B) , which may correspond to the inserted peptide.
DISCUSSION
HEV T=1 VLP is a vaccine candidate that induces protective immunity in non-human primates (12). It can also be used as an antigen carrier to deliver foreign epitopes through oral administration (20) . Therefore, structural analysis of the antibody recognition sites is essential to suppress the neutralization effect of host vector-specific antibodies. For this purpose, we (VLP/Fab4), and the structure of chimeric HEV VLP carrying a B-cell tag at the C-terminus of PORF2 (VLP/C-tag). Docking the PORF2 crystal structure provides spatial information on the HEV antigenic domain and structural guidance to better design foreign epitope insertion.
Structure of the neutralization epitopes
The antigenic properties of HEV and the mechanisms by which it is neutralized are difficult to characterize due to the lack of adequate cell culture replication systems. Therefore, our understanding of HEV immunology is mainly based on studies using recombinant proteins expressed in E. coli (22) and recombinant proteins or HEV VLPs generated using the baculovirus expression systems (15, 23) . Data from these studies indicates that the C-terminal region of PORF2 participates in the immune response against HEV and that the HEV neutralization epitope is conformational. The minimum peptide required to induce HEV neutralizing antibodies corresponds to a region of 148 residues in PORF2, from amino acids 459-607 (32) . This peptide coincides with the P-domain revealed in the crystal structures of PORF2.
The density of the Fab in our cryo-EM structure interfaced entirely with the spikes, thus confirming that the P domain is primarily responsible for HEV antigenicity. Fab4 is a chimpanzee antibody that recognizes ORF2 protein and was isolated using phage display from a cDNA library (24) . Fab4 binds to native HEV virions and recombinant PORF2 peptides containing amino acids 597-607 (25) . We performed fitting with the VLP/Fab4 structure; however, the Fab4 density was too weak to conclusively determine the Fab4 binding site on the surface of HEV VLP. However, the density corresponding to the Fab4 molecule did cover amino acid 606 (data not shown). It is not clear why Fab224 appeared not to interact with peptides lacking amino acids 599-608 in immunoblot analysis. However, the Fab224 binding site is on October 20, 2017 by guest http://jvi.asm.org/ Downloaded from consistent with the critical antigenic residues determined previously using mutagenesis. It was found that double mutations that changed residues E479 and K534 or Y485 and I529 to alanine selectively abrogated PORF2 reactivity with neutralizing antibodies (11) . Another set of mutants defined the same region as the HEV antigenic domain, with antibody recognition residues spreading over the AB, CD and EF loops (31) . The antibodies used in both experiments were neutralizing antibodies; therefore, the Fab224 binding surface is part of the dominant neutralization site, suggesting that the monoclonal antibody Fab224 is a neutralizing antibody.
This neutralization site partially overlaps with the receptor binding site (31) , and antibody binding may create spatial hindrance that prevents HEV VLPs from attaching to the cell surface.
Insertion sites for foreign epitopes Because they are highly organized capsids that mimic the overall structure of virus particles, VLPs are a robust means by which to simultaneously carry small molecules, peptide antigenic epitopes, and DNA vaccines from heterogeneous sources to target disease sites.
However, this rational vaccine design relies on excellent VLP structural information so that epitopes can be effectively conjugated to the VLP surface. In previous study, rather than selecting PORF2 insertion sites on the basis of structural information, six insertion sites were selected according to restriction enzyme sites located either internally (four sites) or in the N-or C-terminus of PORF2. The internal sites are located after residues A179, R366, A507, and R542.
Fusion proteins carrying insertions at sites A179 and R336 failed completely to produce VLPs, and insertions at A507 and R542 greatly reduced VLP production (20) . Crystal structure data revealed that the spatial position of these sites is disadvantageous. Residue A179 is located in the S domain in the middle of a -helix, which is necessary for the integrity of the S domain and its Although located within the P domain, the side chain of R542 is within the dimeric interface and guides the hydrophobic interaction of the two monomers. Replacement of R542 may misalign the orientation between two P domains and weaken the dimeric interaction between PORF2
proteins. Residue A507 in the P-domain plays an important role in maintaining P domain orientation by fixing the angle of the long proline-rich hinge. Moreover, none of the four residues are exposed on the surface of VLPs, although some of them are located on the surface of individual PORF2 subunits (Fig 4C and 4D) . Therefore, insertion of a foreign sequence at these sites does not interfere with the expression of individual proteins but rather hinders the assembly of HEV VLPs. The crystal structure revealed that the C-terminus is exposed on the surface of VLPs, while the N-terminus points toward the VLP center. Therefore, insertion at these two sites does not inhibit VLP assembly; however, the C-terminus is more suitable for tethering bulky foreign antigenic sequences, as was shown in a previous report (20) .
The cryo-EM structure of the chimeric HEV VLP/C-tag suggested that the B-cell tag was located at the lateral side of the spike, not far from residue A606 (C-terminal end in the crystal structure) (Fig 5A) . This density is located beneath the 
